|
Michael Tansey M.D. Ph.D. joined the Company in 2006 as Executive Vice President and Chief Medical Officer. Dr. Tansey has more than 25 years of pharmaceutical industry experience where he has had increasing responsibility for all aspects of product development including global clinical development plans clinical and medical operations regulatory affairs and post approval clinical marketing support. From 1996 until 2003 Dr. Tansey was Chief Medical Officer of Pharmacia and Upjohn and then Chief Medical Officer and Senior Vice President of Medical Development and a member of the Chief Executive's Operations Committee for Pharmacia Corporation. Prior to this he worked at Hoechst AG Rhone Poulenc Rorer and Glaxo. After Pfizer's acquisition of Pharmacia Dr. Tansey founded a consulting group Competitive Drug Development LLC and has since guided more than 12 companies in the U.S. Europe and Asia to optimize their development processes and plans. During this time Dr. Tansey also worked part-time as Executive Director of Clinical Operations for a contract clinical research organization and as part-time CMO for NovaCardia a biotechnology company. He is a member of the board of directors of invivodata Inc. and Vivometrics. | 